In Brief This Week: Agilent; PerkinElmer; Evotec, AstraZeneca; Cancer Genetics; GeneWiz; NeoGenomics; More | GenomeWeb

NEW YORK (GenomeWeb News) – Agilent Technologies said this week it is collaborating with the Korea Advanced Institute of Science and Technology to advance development of inorganic analytical technology. The South Korean institute recently created the Inorganic Analysis Technology Cooperation Center, which is equipped with Agilent's mass spectrometry instruments and is focused on applications in energy, semiconductors, advanced materials, and nanotechnology. The center will be equipped with Agilent's ICP-MS and ICP-OES platforms.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.

Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.

Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.

A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.